ClinicalTrials HQ

Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis

Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis

Not yet recruiting · NCT07674745 · Registry updated 2026-07-01
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary FibrosisDisease Attributes, Disease Progression, Pathologic Processes, Pathological Conditions, Signs and Symptoms, idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorderNot yet recruitingPhase 22026-07-01NCT07674745

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
University of Alabama at Birmingham467

9 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Loyola UniversityChicagoUnited States2
Northwestern UniversityChicagoUnited States727
Temple UniversityPhiladelphiaUnited States50
Thomas Jefferson UniversityPhiladelphiaUnited States165
University of Alabama at BirminghamBirminghamUnited States1
University of KansasKansas CityUnited States1
University of North CarolinaChapel HillUnited States101
University of PittsburghPittsburghUnited States1
University of UtahSalt Lake CityUnited States106